日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PANTAX: a phase Ib clinical trial of the efflux pump inhibitor SCO-101 in combination with gemcitabine and nab-paclitaxel in non-resectable or metastatic pancreatic cancer

PANTAX:一项针对不可切除或转移性胰腺癌的Ib期临床试验,研究外排泵抑制剂SCO-101联合吉西他滨和白蛋白紫杉醇的疗效。

Shim, Susy; Reinacher-Schick, Anke; Kraeft, Anna-Lena; Per Pfeiffer; Tarpgaard, Line Schmidt; Ettrich, Thomas Jens; Kestler, Angelika; Christensen, Signe; Jandu, Haatisha; Nawabi, Mubeen; Roest, Nicklas Lindland; Damstrup, Lars; Vestlev, Peter Michael; Brünner, Nils; Stenvang, Jan; Ladekarl, Morten

New dosing schedules in pre-treated patients with metastatic colorectal cancer

转移性结直肠癌既往治疗患者的新给药方案

Pfeiffer, Per; Tarpgaard, Line Schmidt

Steroids and/or Non-Steroidal Anti-Inflammatory Drugs as Postoperative Treatment after Trabeculectomy-12-Month Results of a Randomized Controlled Trial

类固醇和/或非甾体类抗炎药作为小梁切除术后治疗——一项随机对照试验的12个月结果

Ahmadzadeh, Afrouz; Kessel, Line; Schmidt, Bo Simmendefeldt; Kolko, Miriam; Bach-Holm, Daniella

Outcome of patients with peritoneal metastasis from ovarian cancer treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

采用加压腹腔内气溶胶化疗(PIPAC)治疗卵巢癌腹膜转移患者的疗效

Foslund, Ingrid Terese; von Magius, Sahra Aisha Vinholt; Ainsworth, Alan Patrick; Detlefsen, Sönke; Fristrup, Claus Wilki; Knudsen, Anja Oer; Mortensen, Michael Bau; Tarpgaard, Line Schmidt; Jochumsen, Kirsten Marie; Graversen, Martin

Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol

评估新辅助帕博利珠单抗治疗 I-III 期 MMR 缺陷型结肠癌患者的疗效和安全性:一项全国性、多中心、前瞻性、单臂 II 期研究方案

Justesen, Tobias Freyberg; Gögenur, Ismail; Tarpgaard, Line Schmidt; Pfeiffer, Per; Qvortrup, Camilla

Angiogenesis inhibitors for metastatic colorectal cancer

转移性结直肠癌的血管生成抑制剂

Pfeiffer, Per; Liposits, Gabor; Taarpgaard, Line Schmidt

miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells

miR-625-3p 通过靶向 MAP2K6-p38 信号传导来调节人类结直肠腺癌细胞中的奥沙利铂耐药性

Mads Heilskov Rasmussen, Iben Lyskjær, Rosa Rakownikow Jersie-Christensen, Line Schmidt Tarpgaard, Bjarke Primdal-Bengtson, Morten Muhlig Nielsen, Jakob Skou Pedersen, Tine Plato Hansen, Flemming Hansen, Jesper Velgaard Olsen, Per Pfeiffer, Torben Falck Ørntoft, Claus Lindbjerg Andersen